Related Experiment Videos
Fatal pulmonary fibrosis from low-dose bleomycin therapy
Southern Medical Journal
|May 1, 1987
Summary
Fatal bleomycin pulmonary toxicity can occur at any dosage. This case highlights that routine tests may miss early, reversible toxicity, emphasizing the need for vigilance in patients receiving bleomycin sulfate.
Area of Science:
- Pulmonary Medicine
- Oncology
- Toxicology
Background:
- Bleomycin sulfate is a chemotherapy agent used in treating non-Hodgkin's lymphoma.
- Pulmonary toxicity is a known, potentially fatal side effect of bleomycin therapy.
- Early detection of bleomycin-induced lung injury is challenging.